{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:52:54Z","timestamp":1791971574750,"version":"4.3.4"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000282","name":"Sir Jules Thorn Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000282","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PCEFP3_203343"],"award-info":[{"award-number":["PCEFP3_203343"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PZ00P3_174063"],"award-info":[{"award-number":["PZ00P3_174063"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.bcp.2022.115194","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T08:47:18Z","timestamp":1659084438000},"page":"115194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Mechanism of inhibition of bacterial RNA helicases by diazo dyes and implications for antimicrobial drug development"],"prefix":"10.1016","volume":"204","author":[{"given":"St\u00e9phane","family":"Hausmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Geiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bcp.2022.115194_b0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrm3154","article-title":"From unwinding to clamping - the DEAD box RNA helicase family","volume":"12","author":"Linder","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2022.115194_b0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-0716-0935-4_2","article-title":"30 Years of RNA Helicases","volume":"2209","author":"Valentini","year":"2021","journal-title":"Methods Mol. Biol. (Clifton N.J.)"},{"issue":"5","key":"10.1016\/j.bcp.2022.115194_b0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1515\/hsz-2020-0362","article-title":"Regulation of RNA helicase activity: principles and examples","volume":"402","author":"Donsbach","year":"2021","journal-title":"Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/rna.21879","article-title":"DExD\/H-box RNA helicases in ribosome biogenesis","volume":"10","author":"Martin","year":"2013","journal-title":"RNA Biol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4161\/rna.22547","article-title":"RNA helicases in splicing","volume":"10","author":"Cordin","year":"2013","journal-title":"RNA Biol."},{"issue":"6","key":"10.1016\/j.bcp.2022.115194_b0030","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1042\/BST20170095","article-title":"Distinct RNA-unwinding mechanisms of DEAD-box and DEAH-box RNA helicase proteins in remodeling structured RNAs and RNPs","volume":"45","author":"Gilman","year":"2017","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0035","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1146\/annurev-biochem-060713-035546","article-title":"RNA helicase proteins as chaperones and remodelers","volume":"83","author":"Jarmoskaite","year":"2014","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bcp.2022.115194_b0040","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.2741\/4038","article-title":"Superfamily 2 helicases","volume":"17","author":"Byrd","year":"2012","journal-title":"Front. Biosci. (Landmark Edition)"},{"issue":"6","key":"10.1016\/j.bcp.2022.115194_b0045","doi-asserted-by":"crossref","first-page":"751","DOI":"10.4161\/rna.20090","article-title":"RNA helicases in infection and disease","volume":"9","author":"Steimer","year":"2012","journal-title":"RNA Biol."},{"key":"10.1016\/j.bcp.2022.115194_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2015.00039","article-title":"Helicases and human diseases","volume":"6","author":"Uchiumi","year":"2015","journal-title":"Front. Genet."},{"issue":"11","key":"10.1016\/j.bcp.2022.115194_b0055","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1093\/nar\/gkl408","article-title":"RNA helicases and abiotic stress","volume":"34","author":"Owttrim","year":"2006","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.bcp.2022.115194_b0060","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.bbcan.2017.09.006","article-title":"Targeting RNA helicases in cancer: The translation trap","volume":"1868","author":"Heerma van Voss","year":"2017","journal-title":"Biochimica et biophysica acta Rev. Cancer"},{"issue":"7516","key":"10.1016\/j.bcp.2022.115194_b0065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature13485","article-title":"RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer","volume":"513","author":"Wolfe","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2022.115194_b0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/978-1-0716-0935-4_3","article-title":"Known Inhibitors of RNA Helicases and Their Therapeutic Potential","volume":"2209","author":"Abdelkrim","year":"2021","journal-title":"Methods Mol. Biol. (Clifton N.J.)"},{"issue":"7","key":"10.1016\/j.bcp.2022.115194_b0075","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/1087057113482586","article-title":"Discovering new medicines targeting helicases: challenges and recent progress","volume":"18","author":"Shadrick","year":"2013","journal-title":"J Biomol Screen"},{"issue":"4","key":"10.1016\/j.bcp.2022.115194_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005223","article-title":"Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol","volume":"4","author":"Cencic","year":"2009","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.bcp.2022.115194_b0085","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.3390\/md11093410","article-title":"Hippuristanol reduces the viability of primary effusion lymphoma cells both in vitro and in vivo","volume":"11","author":"Ishikawa","year":"2013","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bcp.2022.115194_b0090","first-page":"541","volume":"26","author":"Naineni","year":"2020","journal-title":"A comparative study of small molecules targeting eIF4A, RNA"},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bmc.2013.11.046","article-title":"Second-generation derivatives of the eukaryotic translation initiation inhibitor pateamine A targeting eIF4A as potential anticancer agents","volume":"22","author":"Low","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2022.115194_b0100","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.molcel.2005.10.008","article-title":"Inhibition of eukaryotic translation initiation by the marine natural product pateamine A","volume":"20","author":"Low","year":"2005","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.onc.1206483","article-title":"Association of Vimentin overexpression and hepatocellular carcinoma metastasis","volume":"23","author":"Hu","year":"2004","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bcp.2022.115194_b0110","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/onc.2013.107","article-title":"DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2\/Slug\/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer","volume":"33","author":"Wu","year":"2014","journal-title":"Oncogene"},{"issue":"7409","key":"10.1016\/j.bcp.2022.115194_b0115","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature11329","article-title":"Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations","volume":"488","author":"Pugh","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ng.3726","article-title":"Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias","volume":"49","author":"Dunford","year":"2017","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/onc.2017.308","article-title":"Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment","volume":"37","author":"Heerma van Voss","year":"2018","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bcp.2022.115194_b0130","doi-asserted-by":"crossref","first-page":"648","DOI":"10.15252\/emmm.201404368","article-title":"Targeting DDX3 with a small molecule inhibitor for lung cancer therapy","volume":"7","author":"Bol","year":"2015","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2022.115194_b0135","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/ml100281b","article-title":"Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring System","volume":"2","author":"Kondaskar","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"issue":"21","key":"10.1016\/j.bcp.2022.115194_b0140","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1158\/0008-5472.CAN-16-0440","article-title":"RK-33 Radiosensitizes Prostate Cancer Cells by Blocking the RNA Helicase DDX3","volume":"76","author":"Xie","year":"2016","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bcp.2022.115194_b0145","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/rmv.1845","article-title":"RNA helicase DDX3: at the crossroad of viral replication and antiviral immunity","volume":"25","author":"Valiente-Echeverr\u00eda","year":"2015","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.bcp.2022.115194_b0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.antiviral.2015.03.014","article-title":"The flavivirus NS2B\u2013NS3 protease\u2013helicase as a target for antiviral drug development","volume":"118","author":"Luo","year":"2015","journal-title":"Antiviral Res."},{"issue":"3","key":"10.1016\/j.bcp.2022.115194_b0155","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12250-020-00242-1","article-title":"SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts","volume":"35","author":"Shu","year":"2020","journal-title":"Virologica Sinica"},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006160","article-title":"Identification of novel leishmanicidal molecules by virtual and biochemical screenings targeting Leishmania eukaryotic translation initiation factor 4A","volume":"12","author":"Harigua-Souiai","year":"2018","journal-title":"PLoS Negl.Trop. Dis."},{"issue":"12","key":"10.1016\/j.bcp.2022.115194_b0165","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.1093\/nar\/gkab503","article-title":"The DEAD-box RNA helicase RhlE2 is a global regulator of Pseudomonas aeruginosa lifestyle and pathogenesis","volume":"49","author":"Hausmann","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.bcp.2022.115194_b0170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/eri.13.12","article-title":"Clinical relevance of the ESKAPE pathogens","volume":"11","author":"Pendleton","year":"2013","journal-title":"Expert Rev. Anti-Infective Ther."},{"issue":"2","key":"10.1016\/j.bcp.2022.115194_b0175","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/clinids\/5.2.279","article-title":"Infections caused by Pseudomonas aeruginosa","volume":"5","author":"Bodey","year":"1983","journal-title":"Rev. Infect. Dis."},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0180","doi-asserted-by":"crossref","DOI":"10.1186\/cc13697","article-title":"Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes","volume":"18:R17","author":"Lu","year":"2014","journal-title":"Crit. Care (London England)"},{"issue":"8","key":"10.1016\/j.bcp.2022.115194_b0185","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol. Adv."},{"issue":"3","key":"10.1016\/j.bcp.2022.115194_b0195","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet. Infect. Dis"},{"issue":"10","key":"10.1016\/j.bcp.2022.115194_b0200","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1128\/MCB.01555-07","article-title":"A conserved phenylalanine of motif IV in superfamily 2 helicases is required for cooperative, ATP-dependent binding of RNA substrates in DEAD-box proteins","volume":"28","author":"Banroques","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2022.115194_b0205","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0165-022X(82)90031-8","article-title":"Inorganic phosphate assay with malachite green: An improvement and evaluation","volume":"7","author":"Carter","year":"1982","journal-title":"J. Biochem. Bioph. Methods"},{"issue":"2","key":"10.1016\/j.bcp.2022.115194_b0215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.bcp.2022.115194_b0220","doi-asserted-by":"crossref","unstructured":"L. Xu, L. Wang, J. Peng, F. Li, L. Wu, B. Zhang, M. Lv, J. Zhang, Q. Gong, R. Zhang, X. Zuo, Z. Zhang, J. Wu, Y. Tang, Y. Shi, Insights into the Structure of Dimeric RNA Helicase CsdA and Indispensable Role of Its C-Terminal Regions, Structure 25(12) (2017) 1795-1808 e5.","DOI":"10.1016\/j.str.2017.09.013"},{"issue":"12","key":"10.1016\/j.bcp.2022.115194_b0225","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1093\/nar\/gkt323","article-title":"Recognition of two distinct elements in the RNA substrate by the RNA-binding domain of the T. thermophilus DEAD box helicase Hera","volume":"41","author":"Steimer","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2022.115194_b0230","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-60327-475-3_7","article-title":"Quantitative analysis of protein-RNA interactions by gel mobility shift","volume":"488","author":"Ryder","year":"2008","journal-title":"Methods Mol. Biol. (Clifton N.J.)"},{"key":"10.1016\/j.bcp.2022.115194_b0235","article-title":"Mechanism of inhibition of bacterial RNA helicases by diazo dyes and implications for antimicrobial drug development","author":"Hausmann","year":"2022","journal-title":"Mendeley Data"},{"issue":"6","key":"10.1016\/j.bcp.2022.115194_b0240","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nprot.2015.053","article-title":"The Phyre2 web portal for protein modeling, prediction and analysis","volume":"10","author":"Kelley","year":"2015","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0245","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1097-2765(03)00006-6","article-title":"The Q motif: a newly identified motif in DEAD box helicases may regulate ATP binding and hydrolysis","volume":"11","author":"Tanner","year":"2003","journal-title":"Mol. Cell"},{"issue":"24","key":"10.1016\/j.bcp.2022.115194_b0250","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.1021\/bi049852s","article-title":"Studies on three E. coli DEAD-box helicases point to an unwinding mechanism different from that of model DNA helicases","volume":"43","author":"Bizebard","year":"2004","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.bcp.2022.115194_b0255","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bcp.2014.07.033","article-title":"Identification and characterization of human Rad51 inhibitors by screening of an existing drug library","volume":"91","author":"Normand","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2022.115194_b0260","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/17460441.2017.1363734","article-title":"An overview of hydrogen deuterium exchange mass spectrometry (HDX-MS) in drug discovery","volume":"12","author":"Masson","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"issue":"3","key":"10.1016\/j.bcp.2022.115194_b0265","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/pro.5560070309","article-title":"Comparisons between the structures of HCV and Rep helicases reveal structural similarities between SF1 and SF2 super-families of helicases","volume":"7","author":"Korolev","year":"1998","journal-title":"Protein Sci. : Publ. Protein Soc."},{"key":"10.1016\/j.bcp.2022.115194_b0270","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.coph.2014.09.006","article-title":"Update on the antibiotic resistance crisis","volume":"18","author":"Rossolini","year":"2014","journal-title":"Curr. Opin. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2022.115194_b0275","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.tim.2011.04.005","article-title":"Pseudomonas aeruginosa: all roads lead to resistance","volume":"19","author":"Breidenstein","year":"2011","journal-title":"Trends Microbiol"},{"issue":"8","key":"10.1016\/j.bcp.2022.115194_b0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000805","article-title":"Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa","volume":"18","author":"Rezzoagli","year":"2020","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0285","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41429-020-0344-z","article-title":"Possible drugs for the treatment of bacterial infections in the future: anti-virulence drugs","volume":"74","author":"Ogawara","year":"2021","journal-title":"J. Antibiot."},{"issue":"4","key":"10.1016\/j.bcp.2022.115194_b0290","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nrmicro3232","article-title":"Targeting virulence: can we make evolution-proof drugs?","volume":"12","author":"Allen","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0295","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1080\/21505594.2020.1770508","article-title":"Identification of FDA-approved antivirulence drugs targeting the Pseudomonas aeruginosa quorum sensing effector protein PqsE","volume":"11","author":"Baldelli","year":"2020","journal-title":"Virulence"},{"issue":"6","key":"10.1016\/j.bcp.2022.115194_b0300","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s43450-020-00112-7","article-title":"Natural Inhibitors of Quorum-Sensing Factors: a Novel Strategy to Control Pathogenic Bacteria","volume":"30","author":"Pe\u00f1a-Gonz\u00e1lez","year":"2020","journal-title":"Revista Brasileira de Farmacognosia"},{"key":"10.1016\/j.bcp.2022.115194_b0305","doi-asserted-by":"crossref","unstructured":"S.H.E. Kaufmann, Paul Ehrlich: founder of chemotherapy, Nat. Rev. Drug Discovery 7(5) (2008) 373-373.","DOI":"10.1038\/nrd2582"},{"issue":"22","key":"10.1016\/j.bcp.2022.115194_b0310","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.128025","article-title":"The small molecule Chicago Sky Blue promotes heart repair following myocardial infarction in mice","volume":"4","author":"Yifa","year":"2019","journal-title":"JCI insight"},{"issue":"2","key":"10.1016\/j.bcp.2022.115194_b0315","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/nn505980z","article-title":"Nanocarrier-Mediated Inhibition of Macrophage Migration Inhibitory Factor Attenuates Secondary Injury after Spinal Cord Injury","volume":"9","author":"Saxena","year":"2015","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0320","doi-asserted-by":"crossref","first-page":"15307","DOI":"10.1038\/s41598-017-15338-0","article-title":"Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP","volume":"7","author":"Donkers","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.bcp.2022.115194_b0325","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/15226514.2011.586276","article-title":"Adsorption of Chicago Sky Blue on the Langmuir Monolayer and Langmuir-Blodgett Films of Octadecylamine","volume":"48","author":"Pal","year":"2011","journal-title":"J. Macromol. Sci. Part A"},{"issue":"36","key":"10.1016\/j.bcp.2022.115194_b0330","doi-asserted-by":"crossref","first-page":"30653","DOI":"10.1074\/jbc.M112.385583","article-title":"A Novel Allosteric Inhibitor of Macrophage Migration Inhibitory Factor (MIF)*","volume":"287","author":"Bai","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2022.115194_b0335","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/med.10041","article-title":"Selection criteria for drug-like compounds","volume":"23","author":"Muegge","year":"2003","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.bcp.2022.115194_b0340","doi-asserted-by":"crossref","first-page":"e1583","DOI":"10.1371\/journal.pone.0001583","article-title":"Selective Pharmacological Targeting of a DEAD Box RNA Helicase","volume":"3","author":"Lindqvist","year":"2008","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.bcp.2022.115194_b0345","doi-asserted-by":"crossref","first-page":"8689","DOI":"10.1093\/nar\/gky706","article-title":"Chemical genetic inhibition of DEAD-box proteins using covalent complementarity","volume":"46","author":"Barkovich","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2022.115194_b0350","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1054-3589(08)60486-X","article-title":"Suramin: with special reference to onchocerciasis","volume":"15","author":"Hawking","year":"1978","journal-title":"Adv. Pharmacol. Chemother."},{"issue":"3","key":"10.1016\/j.bcp.2022.115194_b0355","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01168-19","article-title":"100 Years of Suramin","volume":"64","author":"Wiedemar","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"16","key":"10.1016\/j.bcp.2022.115194_b0360","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.bmcl.2019.06.041","article-title":"Sulfonamide derivatives as multi-target agents for complex diseases","volume":"29","author":"Apayd\u0131n","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0365","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/1011-1344(92)85018-P","article-title":"Merbromin (mercurochrome) and other xanthene dyes: Quantum yields of triplet sensitizer generation and singlet oxygen formation in alcoholic solutions","volume":"12","author":"Gollnick","year":"1992","journal-title":"J. Photochem. Photobiol., B"},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0370","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1021\/acsami.0c18613","article-title":"Cyanuric chloride-based reactive dyes for use in the antimicrobial treatments of polymeric materials","volume":"13","author":"Tang","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bcp.2022.115194_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.117771","article-title":"Chicago Sky Blue diazo-dye release from poly(methyl methacrylate) (PMMA) electrospun nanofibers","volume":"345","author":"Dias","year":"2022","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bcp.2022.115194_b0380","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.micromeso.2014.04.019","article-title":"A molecular model to explain the controlled release from SBA-15 functionalized with APTES","volume":"195","author":"Doadrio","year":"2014","journal-title":"Microporous Mesoporous Mater."},{"issue":"10","key":"10.1016\/j.bcp.2022.115194_b0385","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1088\/0256-307X\/25\/10\/058","article-title":"Effect of temperature and ionic concentration on self-assembled films of chicago sky blue","volume":"25","author":"Dey","year":"2008","journal-title":"Chin. Phys. Lett."},{"issue":"14","key":"10.1016\/j.bcp.2022.115194_b0390","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1142\/S0217979211100229","article-title":"Molecular self-assembly of chicago sky blue onto solid substrate","volume":"25","author":"Islam","year":"2011","journal-title":"Int. J. Mod Phys B"},{"issue":"6","key":"10.1016\/j.bcp.2022.115194_b0395","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/jac\/dkab015","article-title":"Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections","volume":"76","author":"Parsels","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"issue":"12","key":"10.1016\/j.bcp.2022.115194_b0400","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1177\/1060028020929988","article-title":"Cefiderocol: A Siderophore Cephalosporin","volume":"54","author":"El-Lababidi","year":"2020","journal-title":"Ann. Pharmacother."},{"issue":"4","key":"10.1016\/j.bcp.2022.115194_b0405","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10534-009-9219-2","article-title":"Siderophores as drug delivery agents: application of the \u201cTrojan Horse\u201d strategy","volume":"22","author":"M\u00f6llmann","year":"2009","journal-title":"Biometals"},{"issue":"3-4","key":"10.1016\/j.bcp.2022.115194_b0410","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/10520290310001602404","article-title":"The use of dyes in modern biomedicine","volume":"78","author":"Wainwright","year":"2003","journal-title":"Biotechnic Histochemistry : Off. Publ. Biol. Stain Commission"},{"key":"10.1016\/j.bcp.2022.115194_b0415","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.aca.2016.08.006","article-title":"Hydrogen deuterium exchange mass spectrometry in biopharmaceutical discovery and development - A review","volume":"940","author":"Deng","year":"2016","journal-title":"Anal. Chim. Acta"},{"issue":"19","key":"10.1016\/j.bcp.2022.115194_b0420","doi-asserted-by":"crossref","first-page":"10078","DOI":"10.1074\/jbc.M115.708370","article-title":"Hydrogen\/Deuterium Exchange Kinetics Demonstrate Long Range Allosteric Effects of Thumb Site 2 Inhibitors of Hepatitis C Viral RNA-dependent RNA Polymerase","volume":"291","author":"Deredge","year":"2016","journal-title":"J. Boil. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2022.115194_b0425","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1074\/jbc.M112.431312","article-title":"Enhanced SH3\/Linker Interaction Overcomes Abl Kinase Activation by Gatekeeper and Myristic Acid Binding Pocket Mutations and Increases Sensitivity to Small Molecule Inhibitors* [S]","volume":"288","author":"Panjarian","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"7280","key":"10.1016\/j.bcp.2022.115194_b0430","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature08675","article-title":"Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors","volume":"463","author":"Zhang","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2022.115194_b0435","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4161\/cib.13844","article-title":"Genome-wide comprehensive analysis of human helicases","volume":"4","author":"Umate","year":"2011","journal-title":"Commun. Integr. Biol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522200288X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522200288X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:37:57Z","timestamp":1757770677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522200288X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":87,"alternative-id":["S000629522200288X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115194","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of inhibition of bacterial RNA helicases by diazo dyes and implications for antimicrobial drug development","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115194","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115194"}}